Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.60 |
| ▸ | HTT | P42858 | 2/20 | 0.59 |
| ▸ | LMNA | P02545 | 2/20 | 0.58 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.58 |
| ▸ | PRSS1 | P07477 | 2/20 | 0.56 |
| ▸ | TPSAB1 | Q15661 | 2/20 | 0.56 |
| ▸ | TPSD1 | Q9BZJ3 | 1/20 | 0.56 |
| ▸ | TPSG1 | Q9NRR2 | 1/20 | 0.56 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.54 |
| ▸ | CTSL | P07711 | 1/20 | 0.52 |
| ▸ | CTSB | P07858 | 1/20 | 0.52 |
| ▸ | CTSS | P25774 | 1/20 | 0.52 |
| ▸ | CTSK | P43235 | 1/20 | 0.52 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.52 |
| ▸ | KDM1A | O60341 | 1/20 | 0.52 |
| ▸ | RCOR1 | Q9UKL0 | 1/20 | 0.52 |
| ▸ | PLAU | P00749 | 1/20 | 0.51 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.51 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.51 |
| ▸ | FUCA1 | P04066 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30440860 | 1.00 | ALDH1A1 (0.60) | ALDH1A1HTTLMNASMN1; SMN2PRSS1 | |
| SCHEMBL8178335 | 1.00 | ALDH1A1 (0.60) | ALDH1A1HTTLMNASMN1; SMN2PRSS1 | |
| SCHEMBL126974 | 0.93 | HTT (0.66) | ALDH1A1HTTLMNASMN1; SMN2CTSL | |
| SCHEMBL11783251 | 0.93 | HTT (0.66) | ALDH1A1HTTLMNASMN1; SMN2CTSL | |
| Hydrochloric Acid SCHEMBL8688569 | 0.92 | HTT (0.64) | ALDH1A1HTTLMNASMN1; SMN2CTSL | |
| SCHEMBL8327761 | 0.89 | ALDH1A1 (0.59) | ALDH1A1HTTLMNASMN1; SMN2PRSS1 | |
| SCHEMBL30576720 | 0.89 | PRSS1 (0.71) | ALDH1A1HTTLMNASMN1; SMN2PRSS1 | |
| SCHEMBL31550495 | 0.89 | ALDH1A1 (0.62) | ALDH1A1HTTLMNASMN1; SMN2PRSS1 | |
| SCHEMBL13192100 | 0.88 | HTT (0.65) | ALDH1A1HTTLMNASMN1; SMN2PRSS1 | |
| SCHEMBL8156969 | 0.88 | ALDH1A1 (0.58) | ALDH1A1HTTLMNASMN1; SMN2PRSS1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 303 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122070146-A | Antibody coupling medicine, preparation method and application thereof | 杭州爱科瑞思生物医药有限公司 | 2026-05-19 | — | — | CN | claimed |
| EP-4701738-A1 | BISPECIFIC FUSION PROTEINS WITH IMMUNOSUPPRESSIVE ACTIVITY | FUNDACIÓ HOSPITAL UNIVERSITARI VALL D'HEBRON INSTITUT DE RECERCA - VHIR (ES) | 2026-03-04 | — | — | EP | claimed |
| CN-119894535-A | Oritastatin derivatives and conjugates thereof | 祐方有限公司 | 2025-04-25 | — | — | CN | claimed |
| WO-2025067446-A1 | ANTIBODY-DRUG CONJUGATE TARGETING TROP2, AND PREPARATION METHOD AND USE THEREFOR | 信达生物制药(苏州)有限公司 | 2025-04-03 | — | — | WO | claimed |
| WO-2025067306-A1 | ANTIBODY-DRUG CONJUGATE TARGETING HER3 | 信达生物制药(苏州)有限公司 | 2025-04-03 | — | — | WO | claimed |
| CN-119630672-A | Camptothecin derivative and conjugate thereof, and preparation method and medical application thereof | 一线医药（杭州）有限公司 | 2025-03-14 | — | — | CN | claimed |
| WO-2025054560-A2 | ANTIBODY-DRUG CONJUGATES | NEXTPOINT THERAPEUTICS, INC. (US) | 2025-03-13 | — | — | WO | claimed |
| WO-2025040047-A1 | ANTIBODY-DRUG CONJUGATE, PREPARATION METHOD THEREFOR AND USE THEREOF | 杭州爱科瑞思生物医药有限公司 | 2025-02-27 | — | — | WO | claimed |
| CN-119119176-A | Camptothecin derivatives | 伊缪诺金公司 | 2024-12-13 | — | — | CN | claimed |
| WO-2024223892-A1 | BISPECIFIC FUSION PROTEINS WITH IMMUNOSUPPRESSIVE ACTIVITY | UNIVERSITAT DE BARCELONA (ES) | 2024-10-31 | — | — | WO | claimed |
| EP-4454710-A1 | BISPECIFIC FUSION PROTEINS WITH IMMUNOSUPPRESSIVE ACTIVITY | Universitat de Barcelona (ES) | 2024-10-30 | — | — | EP | claimed |
| WO-2024163598-A2 | PEPTIDES COMPRISING THIOESTER GROUPS, INCLUDING DEPSIPEPTIDE THIOESTERS, METHODS OF MAKING, AND USE THEREOF | BRANDEIS UNIVERSITY (US) | 2024-08-08 | — | — | WO | claimed |
| CN-111051329-B | Hamiltelin derivatives and their antibody drug complexes | 住友制药株式会社 | 2024-07-30 | — | — | CN | claimed |
| CN-118302199-A | Anti-CDH 6 antibodies and antibody-drug conjugates thereof | 普众发现医药科技(上海)有限公司 | 2024-07-05 | — | — | CN | claimed |
| CN-118272356-A | Glutaminase and application thereof | 弈柯莱生物科技(集团)股份有限公司 | 2024-07-02 | — | — | CN | claimed |
| CN-118001423-A | Hydrophilic anti-Nectin-4 antibody coupled drug as well as preparation method and application thereof | 杭州爱科瑞思生物医药有限公司 | 2024-05-10 | — | — | CN | claimed |
| CN-117320757-A | anti-HER 2 antibody-drug conjugates and uses thereof | 祐方有限公司 | 2023-12-29 | — | — | CN | claimed |
| CN-115551552-A | Camptothecin derivatives and conjugates thereof | 祐方有限公司 | 2022-12-30 | — | — | CN | claimed |
| CN-122080119-A | Synthesis method of MC-Gly-Gly-Phe-Gly tetrapeptide linker | — | 2026-05-26 | — | — | CN | disclosed |
| US-4076703-A | 2-O-CHLOROBENZOYL-4-CHLORO-N-METHYL-N(ALPHA)-GLYCYL-GLYCINANILIDE | SHIONOGI & CO., LTD. (JA) | 1978-02-28 | — | — | US | disclosed |